Navigation Links
A novel vaccine proves a shot in the arm for colorectal cancer patients

British researchers have produced a vaccine that activates the immune systems in colorectal cancer patients to attack cancerous cells. //

During a clinical trial of 67 patients, researchers at the University of Nottingham discovered that when the vaccines were injected pre and post surgery of the cancerous growth, it activated the immune cell production in nearly 70 percent of patients. The November 15 issue of Clinical Cancer Research has carried the details of this research.

"This is the first vaccine shown to stimulate TNF-alpha – an immune-system protein that is very effective at killing cancer cells," said Lindy Durrant, senior author of the study and professor of cancer immunotherapy at the university.

The vaccine works by stimulating the patients' immune response to generate infection-fighting white blood cells called T cells, which in turn produce immune system proteins called cytokines that destroy cancer cells. The antibody contained in the vaccine, called 105AD7, was cloned from a patient who survived seven years with liver metastases from colorectal cancer, Durrant explained.

"This is very unusual as most patients die within one year of getting liver metastases," she said. "I thought if this antibody had helped this patient, if we could clone it, it might help others."

105AD7 is structurally similar to CD55, a protein that attaches to sugar molecules and is overexpressed in colorectal cancer cells, protecting them from attack by the body's immune system. While low levels of CD55 occur in all cells exposed to the immune system, increased expression of the protein has been observed in multiple types of tumors, including up to 80 percent of colorectal cancers.

During the trial -- the largest to date looking at 105AD7 plus surgery -- 67 patients with colorectal cancer who were scheduled for surgery to remove their primary tumor were randomly assigned to receive either 100 micrograms of 105AD
'"/>




Page: 1 2

Related medicine news :

1. A novel augmentation
2. Gene enchances radiation therapy - A novel approach to fight cancer
3. Cessation of blood supply to cancer cells may curtail spread, novel research
4. Lice now dried to death by novel dryer
5. New hope for cancer victims – will vaccine cure the deadly bug
6. New vaccine helps allergy and asthma patients
7. Man against HIV – new vaccine ready for human trials
8. New vaccine helps allergy and asthma patients
9. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
10. HIV did not arise from polio vaccine
11. Double impact vaccine

Post Your Comments:
(Date:11/8/2009)...Health Care Reform Bill ,, Critical legislati... all Americans ,, CHICAGO, Nov. 7 /PRNewswire-...epresentatives passed by a vote of 220-215, critic...gthen Medicare for seniors and end discrimination ...ricans out of affordable health coverage. ,, ...
(Date:11/7/2009)...USNewswire/ -- Karen Ignagni, President and CEO of... the following statement today on House passage of...omprehensive health care reform, and we have contr...overhaul of how health insurance is provided. Earl...imination of pre-existing condition exclusions, no...
(Date:11/7/2009)...id A. Cook (GA), Louis J. Goodman (TX), Palmer P. ...ICAGO, Nov. 7 The Ameri... medical society executive leaders with achievemen... and ideals of the medical profession. The awards ...ing meeting in Houston. ,, (Logo: http://www...
(Date:11/7/2009)...ve a responsibility to vigorously oppose abortion ..., WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -...ased the following statement on the news that Card...si,s Affordable Health Care for America Act (H.R. ... quo for abortion is voted upon. ,, "Our Catho...
(Date:11/7/2009)...ns Society of America (PRSA) will bestow the disti...nior vice president of Brand Strategy, Communicati...emony at PRSA,s 2009 International Conference in S...ge of Fellows is one of the profession,s highest i... Fellow PRSA, and 2009 chair of the College of Fel...
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3
...y,s Feinberg School of Medicine has been awarded a... Health for a landmark national research, clinical...ats posed to women by cancer treatment. , When a ...r sends it into remission can destroy a woman,s ab...
...pkins, University of California San, Francisco, ...Profiling, COLUMBIA, S.C., Sept. 6 Collexis (OTC...owledge management (KM),and discovery software, ha...inguished Collexis clients including,Johns Hopkins...
...parents and guardians include child ...rk., Sept. 6 Keeping kids,healthy and safe is a p...ng,the right tips and tools for every stage of a c...ited Children (NCMEC),to host "Baby Days," complim...
...troit Free Press,incorrectly reported that Blue Cr...eneric Prilosec(R) and said it was the first time ...Blue Cross Blue Shield of Michigan has had an awar...er 5, the company did announce that it was paying ...
...porosis Foundation (NOF) has teamed up with Ladies... starting September 8th and culminating on,October...duals across the,country to Start Right, Stay Stro...evention, diagnosis and treatment., Each Start Ri...
...rt Card Provides Information on NY/NJ HMO Qual...LAKE SUCCESS, N.Y., Sept. 6 Health care consumers...nique new tool for evaluating,the region,s hospita...ides data on the cost and quality of care,received...
Other Medicine News:Health News:Don't just save her life, save her fertility 2Health News:Don't just save her life, save her fertility 3Health News:Don't just save her life, save her fertility 4Health News:Don't just save her life, save her fertility 5Health News:Don't just save her life, save her fertility 6Health News:Mayo Clinic to Pilot Collexis' Expert Profiling 2Health News:Mayo Clinic to Pilot Collexis' Expert Profiling 3Health News:The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events 2Health News:The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events 3Health News:The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events 4Health News:Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement 2Health News:National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour 2Health News:First New York/New Jersey Health Care Report Card Released 2Health News:First New York/New Jersey Health Care Report Card Released 3Health News:First New York/New Jersey Health Care Report Card Released 4Health News:First New York/New Jersey Health Care Report Card Released 5
(Date:11/6/2009)...e-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC ...ously approved reverse split of its common stock w... Nov. 9, 2009 on a 1-for-15 split-adjusted basis. ...er the new symbol OXBT. The stock also will have a...omes effective. ,, "This reverse split was over...
(Date:11/6/2009)...wswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(&#...t is developing and marketing Levulan(®) Phot...on patients with common skin conditions, announced...icer, will present a corporate overview at the Mer... November 10, 2009 at 10:00 a.m. ET at the Hotel S...
(Date:11/6/2009)...wire/ -- Kaiser Foundation Health Plan, Inc., Kais...iaries reported today a combined total operating r...ember 30, 2009, compared to $10.2 billion in the t... third quarter was $336 million, compared to $307 ...-operating income was $233 million in the third qu...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 1BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 2BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 4BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 5BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 6BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 7OMG Announces Special Event 3A Terminology Services Information Day 60441 1OMG Announces Special Event 3A Terminology Services Information Day 60441 2OMG Announces Special Event 3A Terminology Services Information Day 60441 3
...er Concordance Compared to FISH and... Include Reporting for HER2 Gene Expression in All... of 2008 -, REDWOOD CITY, Calif., Sept. 6 Genomi...ults from two studies demonstrating,that quantitat...d by the,company,s Oncotype DX(R) breast cancer as...
...Amex: CVM ) announced today that it presented new...ference on Immunogenicity in Amsterdam. The data,p...ident of Research,Cellular Immunology of CEL-SCI, ...ne CEL-2000 prevents or retards the permanent tiss...mal model of the disease. These new,findings furth...
Other Medicine Technology:Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4
Gellhorn Pessary
Ring Pessary
Pyramis
...female urinary stress incontinence (SUI) with a mi...ic (BioArcTM SP) or a transobturator (BioArcTM TO)...em combining synthetic and biologic materials. It ...BioArc utilizes a polypropylene mesh for fixation ...
Medicine Products: